Sirtris' review of sirtuin therapeutics for diseases of aging in Nature Reviews Drug Discovery
Wednesday, October 1, 2008 - 08:28
in Health & Medicine
Sirtris, a GSK company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, announced today that it published a new review article on the growing body of sirtuin research and its potential to treat diseases of aging such as Type 2 Diabetes, mitochondrial disorders, inflammation, cancer, and heart disease. Entitled "SIRTUINS - Novel Therapeutic Targets to Treat Age-Associated Diseases," the review appears in today's issue of the journal Nature Reviews Drug Discovery.
Read the whole article on Physorg
More from Physorg
Related
- Mayo Clinic Proceedings reviews deep brain stimulation to treat psychiatric diseasesMon, 29 Jun 2009, 11:56:34 EDT
- Recent developments at Burnham Institute for Medical Research, May 2009Tue, 12 May 2009, 12:49:46 EDT
- Vitamin D is the 'it' nutrient of the momentMon, 12 Jan 2009, 15:15:25 EST
- New biologic drug is effective against rheumatoid arthritisTue, 6 Oct 2009, 19:52:33 EDT
- Researchers unravel key mechanism of cellular damage in aging and diseaseThu, 24 Jul 2008, 12:42:57 EDT